EANS-News: Epigenomics AG Reports Conclusions from PRESEPT Study Audit
Differences in analytical instrument read-out requires verification and potential retesting of samples measured in laboratory with deviating results Top-line data expected still in Q1 2010 No impact on commercial strategy expected Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this ...